Valuation ratios measure the quantity of an asset or flaw (e.g., earnings) associated with ownership of a specified claim (e.g., a share of ownership of the enterprise).

Current Valuation Ratios
Historical Valuation Ratios (Summary)
Price to Earnings (P/E)
Price to Operating Profit (P/OP)
Price to Sales (P/S)
Price to Book Value (P/BV)

Medtronic PLC, current price multiples

	Medtronic PLC		Abbott Laboratories	Cigna Group	CVS Health Corp.	Elevance Health Inc.	Humana Inc.	Intuitive Surgical Inc.	UnitedHealth Group Inc.		Health Care Equipment & Services		Health Care
Selected Financial Data
Current share price (P)
No. shares of common stock outstanding
Growth rate (g)

Earnings per share (EPS)
Next year expected EPS
Operating profit per share
Sales per share
Book value per share (BVPS)
Valuation Ratios (Price Multiples)
Price to earnings (P/E)
Price to next year expected earnings
Price-earnings-growth (PEG)
Price to operating profit (P/OP)
Price to sales (P/S)
Price to book value (P/BV)

Based on: 10-K (reporting date: 2024-04-26).

If the company price multiple is lower then the price multiple of benchmark then company stock is relatively undervalued.
Otherwise, if the company price multiple is higher then the price multiple of benchmark then company stock is relatively overvalued.

Medtronic PLC, historical price multiples

		Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019
	Price to earnings (P/E)
	Price to operating profit (P/OP)
	Price to sales (P/S)
	Price to book value (P/BV)

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

Download chart

Valuation ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	Medtronic PLC P/E ratio increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	Medtronic PLC P/OP ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	Medtronic PLC P/S ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return.	Medtronic PLC P/BV ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.

Medtronic PLC, historical P/E calculation, comparison to benchmarks

		Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Net income attributable to Medtronic (in millions)
	Earnings per share (EPS)²
	Share price^1, 3
	Valuation Ratio
	P/E ratio⁴
	Benchmarks
	P/E Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	UnitedHealth Group Inc.
	P/E Ratio, Sector
	Health Care Equipment & Services
	P/E Ratio, Industry
	Health Care

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

¹ Data adjusted for splits and stock dividends.

² 2024 Calculation
EPS = Net income attributable to Medtronic ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of Medtronic PLC Annual Report.

⁴ 2024 Calculation
P/E ratio = Share price ÷ EPS
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/E ratio	The P/E ratio tells analyst how much an investor in common stock pays per dollar of current earnings.	Medtronic PLC P/E ratio increased from 2022 to 2023 but then slightly decreased from 2023 to 2024.

Medtronic PLC, historical P/OP calculation, comparison to benchmarks

		Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Operating profit (in millions)
	Operating profit per share²
	Share price^1, 3
	Valuation Ratio
	P/OP ratio⁴
	Benchmarks
	P/OP Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	UnitedHealth Group Inc.
	P/OP Ratio, Sector
	Health Care Equipment & Services
	P/OP Ratio, Industry
	Health Care

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

¹ Data adjusted for splits and stock dividends.

² 2024 Calculation
Operating profit per share = Operating profit ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of Medtronic PLC Annual Report.

⁴ 2024 Calculation
P/OP ratio = Share price ÷ Operating profit per share
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/OP ratio	Because P/E ratio is calculated using net income, the ratio can be sensitive to nonrecurring earnings and capital structure, analysts may use price to operating profit.	Medtronic PLC P/OP ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.

Medtronic PLC, historical P/S calculation, comparison to benchmarks

		Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Net sales (in millions)
	Sales per share²
	Share price^1, 3
	Valuation Ratio
	P/S ratio⁴
	Benchmarks
	P/S Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	UnitedHealth Group Inc.
	P/S Ratio, Sector
	Health Care Equipment & Services
	P/S Ratio, Industry
	Health Care

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

¹ Data adjusted for splits and stock dividends.

² 2024 Calculation
Sales per share = Net sales ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of Medtronic PLC Annual Report.

⁴ 2024 Calculation
P/S ratio = Share price ÷ Sales per share
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/S ratio	An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.	Medtronic PLC P/S ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.

Medtronic PLC, historical P/BV calculation, comparison to benchmarks

		Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019
	No. shares of common stock outstanding¹
	Selected Financial Data (US$)
	Shareholders’ equity (in millions)
	Book value per share (BVPS)²
	Share price^1, 3
	Valuation Ratio
	P/BV ratio⁴
	Benchmarks
	P/BV Ratio, Competitors⁵
	Abbott Laboratories
	Cigna Group
	CVS Health Corp.
	Elevance Health Inc.
	Humana Inc.
	Intuitive Surgical Inc.
	UnitedHealth Group Inc.
	P/BV Ratio, Sector
	Health Care Equipment & Services
	P/BV Ratio, Industry
	Health Care

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

¹ Data adjusted for splits and stock dividends.

² 2024 Calculation
BVPS = Shareholders’ equity ÷ No. shares of common stock outstanding
= ÷ =

³ Closing price as at the filing date of Medtronic PLC Annual Report.

⁴ 2024 Calculation
P/BV ratio = Share price ÷ BVPS
= ÷ =

⁵ Click competitor name to see calculations.

Download chart

Valuation ratio	Description	The company
P/BV ratio	The P/BV ratio is interpreted as an indicator of market judgment about the relationship between a company required rate of return and its actual rate of return.	Medtronic PLC P/BV ratio increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.

	Medtronic PLC	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality
Stock Price Trends

	All companies
Financial Statements
Common-Size Financial Statements
Analysis of Financial Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis of Components of Financial Statements
Financial Reporting Quality
Stock Price Trends

Medtronic PLC (NYSE:MDT)

Common Stock Valuation Ratios (Price Multiples)

Paying user area

Try for free

Current Valuation Ratios

Historical Valuation Ratios (Summary)

Price to Earnings (P/E)

Price to Operating Profit (P/OP)

Price to Sales (P/S)

Price to Book Value (P/BV)